Skip to main content

Tag: United Nations

New UN Drug Report Demonstrates Cannabis Prohibition’s Ineffectiveness

The United Nations has published its 2025 World Drug Report. Included in it is the statistic that an estimated 244 million people are cannabis consumers. While the United Nations Drug Report is saturated with drug war rhetoric, that single statistic demonstrates how ineffective cannabis prohibition policies are when it comes to deterring cannabis use.

Humans have consumed parts of the cannabis plant for thousands of years, and there is no evidence demonstrating that prohibiting cannabis has stopped humans from using cannabis. Conversely, there is considerable evidence that cannabis prohibition policies have harmed a massive list of human lives.

In addition to determining that the world is home to 244 million cannabis consumers, the report also lists the following about cannabis:

  • 76% of cannabis consumers are men, 24% are women
  • 5,749 tons of cannabis flower were seized in 2023, down 8% compared to the previous year
  • 1,236 tons of cannabis ‘resin’ were seized in 2023, up 4% compared to the previous year
  • Africa accounted for 44% cannabis seized worldwide in 2023
  • Cannabis has increased by 34% over the past decade
  • Cannabis use remains highest in North America

“Trafficking in cannabis herb remains mostly an intraregional issue in Western and Central Europe; there continue to be, however, substantial imports of cannabis resin into the subregion from North Africa.” the report stated.

The report places a heavy reliance on the number of people in drug treatment for cannabis as a measurement for ‘growing concerns’ about the substance. However, the report does not mention how many of those people are voluntarily in drug treatment for cannabis versus being forced to go to drug treatment for cannabis against their will.

As part of prohibition penalties in many jurisdictions, people caught with cannabis are forced into drug treatment, whether they truly have a cannabis use problem or not. Using my father as an example, one of the times that he was caught with cannabis, he was forced into drug rehab even though he wasn’t a cannabis consumer for many years at that point.

Despite the rehab staff never finding cannabis in my father’s system via their ongoing drug tests, my father was determined to have ‘problematic cannabis use disorder’ and he was forced to continue with weekly rehab appointments, with each appointment involving a hefty fee to both the rehab facility and the government.

This is important context that needs to be considered whenever cannabis-based drug treatment data is reported, like what is included in the UN report. Cannabis prohibition does not work and harms lives. Regulation is a much more sensible approach to cannabis policy.

A 60+ Year Old International Cannabis Policy Agreement Serves No Useful Purpose In 2023

Last week the United Nations’ International Narcotics Control Board issued a press release in which the international body expressed, “concern over the trend to legalize non-medical use of cannabis, which contravenes the 1961 Single Convention on Narcotic Drugs.”

In its 2022 Annual Report, the International Narcotics Control Board outlined the following, as also mentioned in last week’s press release:

  • notes that the 1961 Single Convention on Narcotic Drugs classified cannabis as highly addictive and liable to abuse, and that any non-medical or non-scientific use of cannabis contravenes the Convention;
  • expresses concern that this trend among a small number of governments is leading to higher consumption, negative health effects and psychotic disorders;
  • finds the impact of legalizing cannabis on society difficult to measure because legislative models vary from country to country and data is still limited;
  • voices concern that many countries continue to have difficulties procuring enough controlled substances for medical treatment, including during emergency situations;
  • highlights that countries are confiscating a high number of non-scheduled chemicals and designer precursors used in illicit drug manufacture and is concerned about the global spread of these substances.

Coupled with the points listed above, the press release also provided various arguments and talking points to seemingly portray cannabis legalization in as negative a light as possible. The press release also seemed to ignore quite a bit of real-world context, so I figured I would provide some below.

1961 Single Convention on Narcotic Drugs

One of the most popular talking points among cannabis opponents as legalization continues its march across the globe is that legalization violates the 1961 Single Convention on Narcotic Drugs. For many years opponents would point to the international agreement as ‘justification’ for preventing legalization efforts worldwide. After all, opponents benefit from the status quo, so it is not surprising that they will point to this particular agreement and leverage it to try to slow down the legalization process anywhere and everywhere.

Unfortunately for opponents, the legalization genie is already out of the bottle. Uruguay became the first country to pass a national adult-use legalization measure back in 2013. Canada followed suit in 2018. In late 2021, Malta also passed a national legalization measure. Germany is expected to see a governing coalition-backed legalization measure introduced in the near future, and that will likely result in a flood of other countries doing the same.

With all of that in mind, operatively speaking, the 1961 agreement is becoming more and more symbolic in nature with every passing year. If/when Germany passes an adult-use legalization measure and launches regulated sales, the relevance of the 1961 agreement will erode even further. That begs the question – why is it still around in 2023? The existence of the 1961 Single Convention on Narcotic Drugs or not, the reality of the situation is that more countries are going to legalize cannabis for adult use, and no amount of United Nations PR is going to stop it.

Higher Consumption Rates

Another popular anti-cannabis talking point is that ‘consumption rates are increasing in places where cannabis is legal.’ This talking point is a scare tactic that doesn’t provide nearly enough context, presumably by design. For starters, assuming that consumption rates are truly increasing in all legal jurisdictions, cannabis consumption rates are also going up in places where cannabis is not legal, such as Japan, which opponents seem to always fail to point out.

Furthermore, data from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), which is one of the European Union’s decentralized agencies, demonstrates that the countries in Europe with the highest cannabis consumption rates are not those that have passed legalization measures. For young adults (age 15-34), which are often the focus of expressed ‘concerns’ from cannabis opponents, Czechia has the highest reported consumption rate (22.9%) for reported past-year use, followed by France (21.8%), Italy (20.9%), and Croatia (20.3%).

Malta is the only European country to have passed an adult-use cannabis legalization measure so far, and while it’s still very early in the legalization implementation process, the EMCDDA estimates that “around 4.3% of those aged 18-65 years reported having used cannabis during their lifetime” in Malta. That’s ‘at least once in a lifetime’ versus the ‘used in the last year’ measurement that was referenced in the preceding paragraph.

Being that the number is very low to begin with, increased access to cannabis may indeed result in more people consuming it in Malta in the coming years. Keep that statistic in mind when inevitably cannabis opponents start acting like the sky is about to fall over Malta. Even if the consumption rate doubled, it would still be less than 10%, which in the grand scheme of things is far from being on the high side of the consumption rate spectrum (no pun intended). All the while it is also worth noting that just because people may be consuming more cannabis, that in itself is not a bad thing.

Concerns Regarding Inputs

One line that particularly stood out to me in the press release at the heart of this article was, “…countries are confiscating a high number of non-scheduled chemicals and designer precursors used in illicit drug manufacture and is concerned about the global spread of these substances.” Isn’t this an argument for legalization?

In an unregulated market, there are essentially no rules outside of ‘do not get caught.’ Producers, transporters, and sellers in an unregulated market can add whatever they want to the cannabis during various phases of its life cycle and it often goes completely undetected. This is not to say that all unregulated cannabis is tainted, however, without proper testing there’s no way to know what is ‘clean’ and what is not.

Compare that to a regulated market in which certain substances are prohibited from being added to the cannabis life cycle, such as pesticides, herbicides, harmful nutrients, and “non-scheduled chemicals and designer precursors.” Lab testing and site reviews are mandatory in a regulated system to detect and prevent the use of such substances. If tainted cannabis is truly a concern of the UN then the UN should be promoting cannabis reform efforts around the globe instead of trying to hinder them with anti-cannabis propaganda.

United Nations To Vote On Cannabis Rescheduling

This could prove to be a very big week for cannabis at the international level with the United Nations’ Commission on Narcotic Drugs voting on a series of cannabis policy recommendations from the World Health Organization.

The Commission has met on several occasions to discuss the recommendations from the World Health Organization, including a recommendation to reschedule cannabis, however, there has yet to be a vote.

Voting was expected to occur earlier in 2020, but due to various delays, it never happened. That will change tomorrow when the Commission finally votes on the recommendations. Below is what is being considered, as reported by Marijuana Moment:

1. Remove marijuana from Schedule IV of the 1961 Single Convention.

2. Add THC and dronabinol (synthetic THC medication) to Schedule I of the 1961 Convention and, if approved, delete them from Schedule II of the 1971 Convention.

3. If the second recommendation is adopted, add tetrahydrocannabinol to Schedule I of the 1961 Convention and, if approved, delete it from Schedule I of the 1971 Convention.

4. Delete “extracts and tinctures of cannabis” from Schedule I of the 1961 Convention.

5. Add footnote to clarify that CBD products containing no more than 0.2 percent THC are not subject to international control.

6. Add “preparations containing dronabinol” to Schedule III of the 1961 Convention.

Only time will tell what gets approved and what does not. International cannabis policy is extremely outdated, and binding international treaties are often cited by countries as to why lawmakers will not end cannabis prohibition in those countries.

Right now two countries, Uruguay and Canada, have legalized cannabis for adult-use. Dozens of countries have legalized cannabis for medical use. Cannabis is being imported and exported between a growing list of nations.

It is beyond time that international cannabis policy was updated to reflect what is actually happening in the real world.

Cannabis prohibition has failed, and it’s time for a more sensible approach at the global level so that at the national level countries can proceed with getting on the right side of history.

United Nations Pushes Back Cannabis Discussion Again

The United Nations, rather unbelievably in the face of the Covid-19 pandemic, is again delaying its decision on medical cannabis reclassification. Coronavirus is, like AIDS and SARs, a retrovirus. Indeed many of the early treatments now being considered for those who develop symptoms may come from HIV drugs already tested for use in the SARs epidemic at the beginning of the century.

However antivirals are tough to take on their own, and further, patients have fairly routinely found that non-smoked cannabis, in particular, helps them deal with the not insignificant side effects of these treatments. That is also why, as of the early 1980s, Dronabinol, or synthetic cannabis, was approved for medical use.

The first country to visibly protest the decision to delay the UN reclassification was the U.S. but it is likely that this decision was also not popular in Europe, where the entire medical discussion and scheduling is in the room in a big way right now as countries move to incorporate cannabis as a prescription drug. One of the reasons that law enforcement in the U.S. at least wants a focus on this topic now is that the U.S. is also still in the throes of an opioid epidemic.

The World Health Organization (WHO) recommended that cannabis be moved to the least restrictive “Schedule I” or least restrictive schedule under the 1961 Single Convention on Narcotic Drugs. Cannabis is currently classified as a Schedule IV medication.

The UN Commission on Narcotic Drugs (CND) considered rescheduling cannabis last year in March. This was delayed for a year, but at the beginning of March 2020, the committee again voted to push this to the end of the year.

Is Cannabis Actually A “Narcotic” Drug At All?

One of the larger questions in the room is whether the plant itself can be discussed in terms of a “narcotic” – especially when it is used as an antiviral rather than to help pain patients. This conversation, as a result, is likely also to see the descheduling of low THC plants like hemp. However, beyond this, the outdated science of prohibition is in the room on the viral discussion in a big way.

Of course, healthy people who consume this drug can become “high.” This is the first reason that cannabis was classified as a “narcotic.” However, patients who consume THC long term, particularly for pain caused by spasticity and viral conditions like AIDS, also report that this effect goes away with longer-term use.

All of these issues are now up in the air as the world grapples with the worst public health crisis of a generation. But cannabis, again, is undoubtedly in the room.

Be sure to join the International Cannabis Business Conference in Europe this year, starting with the rescheduled International Cannabis Business Conference in Berlin at the end of July for updates on a changing international drug schedule!